{Reference Type}: Journal Article
{Title}: The Kidney in Obesity: Current Evidence, Perspectives and Controversies.
{Author}: Kounatidis D;Vallianou NG;Stratigou T;Voukali M;Karampela I;Dalamaga M;
{Journal}: Curr Obes Rep
{Volume}: 0
{Issue}: 0
{Year}: 2024 Aug 14
{Factor}: 8.023
{DOI}: 10.1007/s13679-024-00583-y
{Abstract}: <B>OBJECTIVE: </B>As obesity and chronic kidney disease (CKD) remain a public health issue, we aim to elaborate on their complex relationship regarding pathogenetic mechanisms and therapeutic potential as well. The purpose of this review is to enhance our understanding of the interplay between obesity and CKD in order to timely diagnose and treat obesity-related CKD.<BR><B>RESULTS: </B>Obesity and CKD pose significant intertwined challenges to global health, affecting a substantial portion of the population worldwide. Obesity is recognized as an independent risk factor, intricately contributing to CKD pathogenesis through mechanisms such as lipotoxicity, chronic inflammation, and insulin resistance. Recent evidence highlights additional factors including hemodynamic changes and intestinal dysbiosis that exacerbate kidney dysfunction in obese individuals, leading to histologic alterations known as obesity-related glomerulopathy (ORG). This narrative review synthesizes current knowledge on the prevalence, pathophysiology, clinical manifestations, and diagnostic strategies of obesity-related kidney disease. Furthermore, it explores mechanistic insights to delineate current therapeutic approaches, future directions for managing this condition and controversies. By elucidating the multifaceted interactions between obesity and kidney health, this review aims to inform clinical practice and stimulate further research to address this global health epidemic effectively.